Rheumatology Center of Excellence

Supporting rheumatology patients living with a rare condition

Orsini’s Rheumatology Center of Excellence launched in 2026 with our first program for fibrodysplasia ossificans progressiva (FOP). Our dedicated Therapy Care Teams work with the physician’s office and insurance on a patient’s behalf so that our patients and their family have more time to focus on their treatment and quality of life. We are here to listen, provide counseling on treatment, including side-effect management, and assist with sourcing third-party financial assistance.

Explore Our Rheumatology Therapies

Benefits

Improving the Patient Experience, Every Time

Dedicated Care Team

Receive personalized support from a dedicated Therapy Care Team, including a primary pharmacy contact, clinical education, side-effects management, and scheduled refill calls.

Home Health Nursing

Access nationwide nursing support for in-home treatment or self-administration training. Our nurses provide clinical support to help patients achieve their treatment goals.

Insurance Coverage

Secure treatment coverage with assistance navigating payor and plan requirements. Our team proactively works with prescribers to obtain prior authorization and support appeals.

Free Care Overnight Shipping

Ensure medication and essential medical supplies arrive when and where patients need them through coordination across prescribers, patients, and care teams to arrange free overnight shipping.

Financial Assistance

Minimize financial exposure through financial assistance programs. We successfully identify and assist in enrolling patients into manufacturer co-pay and foundation support programs.

24/7/365 Access to a Pharmacist

Gain continuous access to a pharmacist, 24/7/365, ensuring ongoing care and clinical support for patients and prescribers to achieve better outcomes.

Support

Rheumatology Conditions Supported

Explore the rare rheumatology conditions Orsini supports below.

About Dermatomyositis

Dermatomyositis is a rare autoimmune inflammatory disease that primarily affects the muscles and skin. In this condition, the body’s immune system mistakenly attacks healthy tissues, leading to progressive muscle weakness and distinctive purplish or reddish skin rashes. It can occur in both adults and children.

Dermatomyositis Therapies Supported

Full Name	LISRAYA™ (brepocitinib)
Drug	brepocitinib
Manufacturer	Priovant Therapeutics
Route of Administration	Oral
Site of Care	Home
Approved Indication	The treatment of dermatomyositis in adult patients
Disease	Dermatomyositis
Therapeutic Area	Rheumatology, Neurology, Dermatology
Phone Number	847-453-3265
Fax Number	877-471-5764
Enrollment Form Link	Enrollment Form
Product Website	lisrayahcp.com

About Fibrodysplasia Ossificans Progressiva (FOP)

Fibrodysplasia ossificans progressiva is a rare genetic disorder caused by a mutation in the ACVR1 gene, in which muscles, tendons, ligaments, and other connective tissues gradually turn into bone. It is associated with restricted movement, locked joints, progressive loss of mobility, and shortened life expectancy. Symptoms often begin in early childhood, and many people with FOP are born with characteristic malformations of the big toes.

FOP Therapies Supported

Full Name	PASATRU™ (garetosmab-grts)
Drug	PASATRU™
Manufacturer	Regeneron Pharmaceuticals
Route of Administration	Intravenous
Site of Care	Home or Healthcare Facility
Approved Indication	To reduce formation of new heterotopic ossification (HO) lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva (FOP)
Disease	Fibrodysplasia Ossificans Progressiva (FOP)
Therapeutic Area	Rheumatology, Genetics
Enrollment Form Link	www.pasatruhcp.com
Phone Number	847-464-8049
Fax Number	847-892-1181
Product Website	www.pasatruhcp.com